Article info
Tumor board
Association of nivolumab and niraparib in the management of neuroendocrine cancer of the cervix
- Correspondence to Dr Omar Touhami, Gynecologic Oncology Division, Department of Obstetrics and Gynecology, Centre Intégré Universitaire de Santé et Services Sociaux CIUSSS du Saguenay-Lac-Saint-Jean, Sherbrooke University, Chicoutimi, QC G1R 2J4, Canada; touhamiomar{at}yahoo.fr
Citation
Association of nivolumab and niraparib in the management of neuroendocrine cancer of the cervix
Publication history
- Accepted February 6, 2023
- First published April 3, 2023.
Online issue publication
April 03, 2023
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ.